Compare XBIT & ALCO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | XBIT | ALCO |
|---|---|---|
| Founded | 2005 | 1960 |
| Country | United States | United States |
| Employees | N/A | 172 |
| Industry | Pharmaceuticals and Biotechnology | |
| Sector | Health Care | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 75.0M | 297.9M |
| IPO Year | 2015 | 1994 |
| Metric | XBIT | ALCO |
|---|---|---|
| Price | $2.35 | $40.35 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 1 |
| Target Price | N/A | ★ $44.00 |
| AVG Volume (30 Days) | ★ 21.9K | 14.6K |
| Earning Date | 05-08-2026 | 05-11-2026 |
| Dividend Yield | N/A | ★ 0.49% |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 1.03 |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | $39.19 |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $2.09 | $30.89 |
| 52 Week High | $3.61 | $45.01 |
| Indicator | XBIT | ALCO |
|---|---|---|
| Relative Strength Index (RSI) | 38.96 | 43.85 |
| Support Level | $2.35 | $39.98 |
| Resistance Level | $2.41 | $42.55 |
| Average True Range (ATR) | 0.06 | 1.09 |
| MACD | -0.02 | -0.12 |
| Stochastic Oscillator | 21.74 | 24.01 |
XBiotech Inc is a biopharmaceutical company that discovers and develops True Human monoclonal antibodies derived from human donors to replicate the human immune response in the treatment of various diseases. It has developed a pipeline of product candidates using True Human antibodies targeting both inflammatory and infectious diseases. The company's developement pipeline comprises: Natrunix, an antibody targeting IL-1a in oncology (pancreatic cancer), a clinical stage therapeutic for Methicillin Resistant Staphylococcus aureus (MRSA), and several pre-clinical stage therapeutics, including: an oral delivery antibody therapeutic for colon infection by C. difficile; an injectable therapy for varicella zoster (adult chicken pox), the causative agent for shingles; and an influenza therapy.
Alico Inc is a Florida-based agribusiness and land management company that mainly focuses on citrus production and grove conservation. The company operates through two primary business units: Alico Citrus and Land Management and Other Operations. The Alico Citrus segment engages in the cultivation of citrus trees and delivers citrus to the processed and fresh citrus markets. It mainly serves the processed market and sells Hamlin oranges and the Valencia variety to the orange juice processors. The Land Management and Other Operations segment engages in land leasing for recreational, conservation, and mining activities. Alico Citrus delivers the majority of the revenue as the firm's primary operating business unit.